![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 25, 23675-23683, June 24, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Sandwich Domain of Tissue Transglutaminase*



¶
From the
Department of Biochemistry and Molecular Biology and Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201 and
Department of Cell and Molecular Biology, Northwestern University Feinberg Medical School, Chicago, Illinois 61601
Tissue transglutaminase belongs to the multigene transglutaminase family of Ca2+-dependent protein cross-linking enzymes. Unlike other transglutaminases, it is involved in cell-matrix interactions and serves as an adhesion co-receptor for fibronectin. Previous work established that the fibronectin-binding motif(s) is located within the NH2-terminal proteolytic fragment of the protein consisting of residues 1272. Here we identify a novel fibronectin recognition site within this sequence of tissue transglutaminase. Substitution of individual domains of tissue transglutaminase with those from homologous factor XIIIA showed that the major fibronectin-binding site is present within the first
-sandwich domain of the protein. Experiments with deletion mutants of the first domain revealed that amino acids 81140 of tissue transglutaminase are involved in fibronectin binding. Using synthetic peptides encompassing this region, we found that the peptide 88WTATVVDQQDCTLSLQLTT106 inhibited the interaction of tissue transglutaminase with fibronectin and decreased transglutaminase-dependent cell adhesion and spreading. In the three-dimensional structure of the first domain, amino acids 88106 comprise an extended hairpin formed by antiparallel
strands 5 and 6. Mutations of Asp94 and Asp97 within the
5/
6 hairpin to Ala significantly reduced the affinity of tissue transglutaminase for fibronectin, indicating that these residues are critical for fibronectin binding. Identification of the fibronectin-binding site on tissue transglutaminase will help to dissect the role of this protein in cell-matrix interactions.
Received for publication, March 25, 2005 , and in revised form, April 20, 2005.
* This work was supported by National Institutes of Health Grants GM62895 (to A. M. B.) and HL02212 (to L. L). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 15601 Crabbs Branch Way, Rockville, MD 20855. Tel.: 301-738-0725; Fax: 301-738-0740; E-mail: abelk001{at}umaryland.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. A. Johnson, D. M. Rose, and R. A. Terkeltaub Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation J. Cell Sci., July 1, 2008; 121(13): 2256 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sivaramakrishnan, J. V. DeGiulio, L. Lorand, R. D. Goldman, and K. M. Ridge Micromechanical properties of keratin intermediate filament networks PNAS, January 22, 2008; 105(3): 889 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Lai, Y. Liu, W. Li, and C. S. Greenberg Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells FASEB J, December 1, 2007; 21(14): 4131 - 4143. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Zemskov, I. Mikhailenko, D. K. Strickland, and A. M. Belkin Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1 J. Cell Sci., September 15, 2007; 120(18): 3188 - 3199. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Satpathy, L. Cao, R. Pincheira, R. Emerson, R. Bigsby, H. Nakshatri, and D. Matei Enhanced Peritoneal Ovarian Tumor Dissemination by Tissue Transglutaminase Cancer Res., August 1, 2007; 67(15): 7194 - 7202. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lorand Crosslinks in blood: transglutaminase and beyond FASEB J, June 1, 2007; 21(8): 1627 - 1632. [Full Text] [PDF] |
||||
![]() |
L. Xu, S. Begum, J. D. Hearn, and R. O. Hynes GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis PNAS, June 13, 2006; 103(24): 9023 - 9028. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Janiak, E. A. Zemskov, and A. M. Belkin Cell Surface Transglutaminase Promotes RhoA Activation via Integrin Clustering and Suppression of the Src-p190RhoGAP Signaling Pathway Mol. Biol. Cell, April 1, 2006; 17(4): 1606 - 1619. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |